Gotham Therapeutics
Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.
Operating in biotechnology, life science, therapeutics based in Greater New York Area, East Coast, Northeastern US, Gotham Therapeutics was founded in 2017.
Within the biotechnology, life science, therapeutics space, the company focuses on its core offering rather than a broad product line.
The business is associated with Greater New York Area, East Coast, Northeastern US.
The company is listed at the Series_A stage of development.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $54M in funding.
| Sector | Biotechnology, Life Science, Therapeutics |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $54,000,000 |
Website: www.gothamtx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account